Acorda Therapeutics, Inc. facts - Freebase

Embed this Topic

Acorda Therapeutics, Inc.

Legal structure:

Publicly listed company

Industry:

View Acorda Therapeutics, Inc.: Industries »

Business

Address

Acorda Therapeutics, Inc. Headquarters

15 SKYLINE DRIVE

Hawthorne New York 10532

United States of America

Revenue:

Currency	Amount	Valid Date
US$	27,400,000	Dec 31, 2006

Operating income:

Currency	Amount	Valid Date
US$	-21,720,000	Dec 31, 2006

Market capitalization:

Currency	Amount	Valid Date
US$	630,000,000	Dec 31, 2007

Board members:

View Acorda Therapeutics, Inc. board members »

Ticker symbol:

Stock exchange	Ticker symbol
NASDAQ	ACOR

Employees and other personnel:

Person	Title
Mary Fisher	Chief Operating Officer
David Lawrence	Chief Financial Officer
Jane Wasman	Executive Vice President
Jane Wasman	General Counsel
Jane Wasman	Secretary
Andrew Blight	Chief Scientific Officer

View Acorda Therapeutics, Inc. employees and other personnel »

top ↑

You can help improve this topic by adding more facts here

Edit this topic

Last edited Nov 6, 2009 See all topic history »

Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Flag this Topic

Why do you want to flag this topic?

Freebase data is free for use under the CC-BY license.

Learn more about Freebase licensing and attribution